Literature DB >> 3592986

Expression at the cell surface of native fusion protein of the Newcastle disease virus (NDV) strain Italien from cloned cDNA.

D Espion, S de Henau, C Letellier, C D Wemers, R Brasseur, J F Young, M Gross, M Rosenberg, G Meulemans, A Burny.   

Abstract

A cDNA library was constructed with poly(A)+-mRNAs from NDV-Italien infected BHK-21 cells. A clone, that hybridized to the F gene mRNA, was sequenced. A long open reading frame encodes for a protein of 553 amino acids, with a calculated molecular weight of 59,153, consisting of twelve cysteine residues and six potential glycosylation sites. The protein sequence contains a hydrophobic region at the N-terminus of F1 and a presumptive long transmembrane fragment near the C-terminus. Comparison of the F proteins from NDV strains Italien and Australia-Victoria shows that the sequences are very similar, with conservation of most cysteine residues and of the potential glycosylation sites. The F coding sequence was inserted into the genome of vaccinia virus under the control of vaccinia P7.5 transcriptional regulatory sequences. Expression of F protein was demonstrated by indirect immunofluorescence with five anti-F monoclonal antibodies known to react with conformational epitopes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592986     DOI: 10.1007/bf01311336

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  40 in total

1.  Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

2.  Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses.

Authors:  M K Spriggs; R A Olmsted; S Venkatesan; J E Coligan; P L Collins
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

3.  Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein.

Authors:  R G Paterson; T J Harris; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

6.  Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes.

Authors:  M Krystal; R M Elliott; E W Benz; J F Young; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

8.  Coding assignments of the five smaller mRNAs of Newcastle disease virus.

Authors:  P L Collins; G W Wertz; L A Ball; L E Hightower
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

9.  Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action.

Authors:  C D Richardson; P W Choppin
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

10.  Isolation and characterization of the measles virus F1 polypeptide: comparison with other paramyxovirus fusion proteins.

Authors:  T M Varsanyi; H Jörnvall; E Norrby
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

View more
  9 in total

1.  Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.

Authors:  C Letellier; A Burny; G Meulemans
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization.

Authors:  T Toyoda; B Gotoh; T Sakaguchi; H Kida; Y Nagai
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies.

Authors:  C Neyt; J Geliebter; M Slaoui; D Morales; G Meulemans; A Burny
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  The hemagglutinin-neuraminidase (HN) gene of Newcastle disease virus strain Italien (ndv Italien): comparison with HNs of other strains and expression by a vaccinia recombinant.

Authors:  C D Wemers; S de Henau; C Neyt; D Espion; C Letellier; G Meulemans; A Burny
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens.

Authors:  J Taylor; C Edbauer; A Rey-Senelonge; J F Bouquet; E Norton; S Goebel; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  The mode of insertion of the paramyxovirus F1 N-terminus into lipid matrix, an initial step in host cell/virus fusion.

Authors:  R Brasseur; P Lorge; E Goormaghtigh; J M Ruysschaert; D Espion; A Burny
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

7.  Fusion (F) protein gene of Newcastle disease virus: sequence and hydrophobicity comparative analysis between virulent and avirulent strains.

Authors:  L Le; R Brasseur; C Wemers; G Meulemans; A Burny
Journal:  Virus Genes       Date:  1988-07       Impact factor: 2.332

8.  Identification and grouping of Newcastle disease virus strains by restriction site analysis of a region from the F gene.

Authors:  A Ballagi-Pordány; E Wehmann; J Herczeg; S Belák; B Lomniczi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 9.  A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication.

Authors:  Paulo H Verardi; Allison Titong; Caitlin J Hagen
Journal:  Hum Vaccin Immunother       Date:  2012-07-01       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.